glp-1 drugs and breast cancer May Improve Survival for Some Patients Study links GLP-1 drugs to
Description
doi: 10.3389/fphar.2026.1736380 Received 10 November 2025 Revised 20 January 2026 Accepted 21 January 2026 Published 10 February 2026 Volume 17 - 2026 Edited by Madhusudan Prasad Singh, All India Institute of Medical Sciences Raipur, India Reviewed by Hemasri Velmurugan, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), India Prachi Arunima, All India Institute of Medical Sciences Raipur, India Updates Copyright 2026 Wali, Rangraze, Khan, Mufti, El-Tanani and Rizzo
Before starting GLP-1 medication, our medical team will evaluate your health, lifestyle, and metabolic profile
5 GLP-1 trends to expect in 2026: Expanded uses, oral options, and more Originally developed for Type 2 diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists have transformed the weight-loss medication market
Redox Biol 12:854-863
Educate them on the symptoms and advise them to seek medical advice if symptoms occur
These agents, comprising GLP-1 combined molecules with glucagon or other hormones, have been investigated in preclinical studies for NAFLD treatment
